Literature DB >> 22933812

Neuroanatomical substrates of visual hallucinations in patients with non-demented Parkinson's disease.

Soojeong Shin1, Ji Eun Lee, Jin Yong Hong, Mun-Kyung Sunwoo, Young Ho Sohn, Phil Hyu Lee.   

Abstract

BACKGROUND: Visual hallucinations (VH), which are common in patients with Parkinson's disease (PD), lead to increased disability and are a significant predictor of the development of dementia. However, the neuroanatomical basis for VH in non-demented PD patients remains controversial.
METHODS: A total of 110 patients with PD were classified into PD with VH (n=46) and PD without VH (n=64) groups, depending on the presence of VH assessed by the caregiver-based structured interview of the Neuropsychiatric Inventory. We performed voxel-based morphometry (VBM) for grey matter (GM) volume and a region-of-interest-based volumetric analysis of the substantia innominata (SI) between two groups.
RESULTS: The comprehensive neuropsychological assessment showed that PD patients with VH showed more severe cognitive deficits in delayed visual memory and frontal executive functions compared with those without VH. A VBM analysis revealed that PD patients with VH had significantly lower GM volume in the right orbitofrontal, left temporal and left thalamic areas compared with those without VH. The normalised SI volume was significantly reduced in PD patients with VH compared with those without VH (1.28 ± 0.22 vs 1.41 ± 0.25, p=0.005).
CONCLUSIONS: The present study demonstrates that non-demented PD patients with VH exhibited a smaller volume in the frontal, temporal and thalamic areas as well as the SI, suggesting that PD hallucinators may have distinctive neuroanatomical bases relative to PD non-hallucinators.

Entities:  

Mesh:

Year:  2012        PMID: 22933812     DOI: 10.1136/jnnp-2012-303391

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  23 in total

Review 1.  Cortical afferent inhibition abnormalities reveal cholinergic dysfunction in Parkinson's disease: a reappraisal.

Authors:  Raffaele Nardone; Francesco Brigo; Viviana Versace; Yvonne Höller; Frediano Tezzon; Leopold Saltuari; Eugen Trinka; Luca Sebastianelli
Journal:  J Neural Transm (Vienna)       Date:  2017-08-12       Impact factor: 3.575

Review 2.  Minor hallucinations in Parkinson disease: A subtle symptom with major clinical implications.

Authors:  Abhishek Lenka; Javier Pagonabarraga; Pramod Kumar Pal; Helena Bejr-Kasem; Jaime Kulisvesky
Journal:  Neurology       Date:  2019-07-09       Impact factor: 9.910

3.  Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson's disease with hallucinations.

Authors:  Jennifer G Goldman; Glenn T Stebbins; Vy Dinh; Bryan Bernard; Doug Merkitch; Leyla deToledo-Morrell; Christopher G Goetz
Journal:  Brain       Date:  2014-01-29       Impact factor: 13.501

Review 4.  Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.

Authors:  Anna Chang; Susan H Fox
Journal:  Drugs       Date:  2016-07       Impact factor: 9.546

5.  Risk factors for early psychosis in PD: insights from the Parkinson's Progression Markers Initiative.

Authors:  Dominic H Ffytche; Joana B Pereira; Clive Ballard; K Ray Chaudhuri; Daniel Weintraub; Dag Aarsland
Journal:  J Neurol Neurosurg Psychiatry       Date:  2017-04       Impact factor: 10.154

Review 6.  The psychosis spectrum in Parkinson disease.

Authors:  Dominic H Ffytche; Byron Creese; Marios Politis; K Ray Chaudhuri; Daniel Weintraub; Clive Ballard; Dag Aarsland
Journal:  Nat Rev Neurol       Date:  2017-01-20       Impact factor: 42.937

7.  Nonmotor symptom burden grading as predictor of cognitive impairment in Parkinson's disease.

Authors:  Panteleimon Oikonomou; Daniel J van Wamelen; Daniel Weintraub; Dag Aarsland; Dominic Ffytche; Pablo Martinez-Martin; Carmen Rodriguez-Blazquez; Valentina Leta; Corinne Borley; Carolina Sportelli; Dhaval Trivedi; Aleksandra M Podlewska; Katarina Rukavina; Alexandra Rizos; Claudia Lazcano-Ocampo; Kallol Ray Chaudhuri
Journal:  Brain Behav       Date:  2021-03-01       Impact factor: 2.708

8.  Hippocampal subfield atrophy in patients with Parkinson's disease and psychosis.

Authors:  Abhishek Lenka; Madhura Ingalhalikar; Apurva Shah; Jitender Saini; Shyam Sundar Arumugham; Shantala Hegde; Lija George; Venkateswara Reddy; Y C Janardhana Reddy; Ravi Yadav; Pramod Kumar Pal
Journal:  J Neural Transm (Vienna)       Date:  2018-06-01       Impact factor: 3.850

9.  Visual hallucinations in Lewy body disease: pathophysiological insights from phenomenology.

Authors:  Fabrizia D'Antonio; Maddalena Boccia; Antonella Di Vita; Antonio Suppa; Andrea Fabbrini; Marco Canevelli; Francesca Caramia; Marco Fiorelli; Cecilia Guariglia; Stefano Ferracuti; Carlo de Lena; Dag Aarsland; Dominic Ffytche
Journal:  J Neurol       Date:  2022-01-31       Impact factor: 6.682

10.  Pattern of regional cortical thinning associated with cognitive deterioration in Parkinson's disease.

Authors:  Javier Pagonabarraga; Idoia Corcuera-Solano; Yolanda Vives-Gilabert; Gisela Llebaria; Carmen García-Sánchez; Berta Pascual-Sedano; Manuel Delfino; Jaime Kulisevsky; Beatriz Gómez-Ansón
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.